UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BLADDER CANCER IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH CYCLOPHOSPHAMIDE

The Journal of urology, 1998-06, Vol.159 (6), p.1881-1884

1998

Volltextzugriff (PDF)

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

The Lancet (British edition), 2002-12, Vol.360 (9350), p.2018-2025

2002

Volltextzugriff (PDF)

Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years

Journal of neurology, 1977-09, Vol.214 (3), p.173-181

1977

Volltextzugriff (PDF)

Failure of basic protein therapy for multiple sclerosis

Journal of neurology, 1977-01, Vol.216 (1), p.27-31

1977

Volltextzugriff (PDF)

Biochemical findings in multiple sclerosis. II. A detailed study of the serum IgA, IgG and IgM levels of 772 MS patients compared with 226 neurological controls

Journal of neurology, 1976-01, Vol.211 (2), p.135-142

1976

Volltextzugriff (PDF)

Treatment of chronic hepatitis C in patients with human immunodeficiency virus (HIV) with weekly peginterferon alpha-2b plus ribavirin: a multi-centred Belgian study

Acta gastro-enterologica belgica, 2009-10, Vol.72 (4), p.389-393

2009

Volltextzugriff (PDF)

Modulation of immunity in multiple sclerosis: a double-blind levamisole-placebo controlled study in 85 patients

Journal of neurology, 1982-01, Vol.228 (1), p.65-72

1982

Volltextzugriff (PDF)

BLADDER CANCER IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH CYCLOPHOSPHAMIDE

The Journal of urology, 1998-06, p.1881-1884

1998

Volltextzugriff (PDF)

Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)

Acta neurologica Belgica, 1978-05, Vol.78 (3), p.141

1978

Volltextzugriff (PDF)

Effects of immunosuppressive agents and particularly of cyclophosphamide on lymphocytes subsets in treated multiple sclerosis patients

Rivista di neurologia, 1987-05, Vol.57 (3), p.181

1987

Volltextzugriff (PDF)

Continuous Dose-Response Relationship of the LDL-Cholesterol-Lowering Effect of Phytosterol Intake

The Journal of nutrition, 2009-02, Vol.139 (2), p.271-284

2009

Volltextzugriff (PDF)

The effect of plant sterols on serum triglyceride concentrations is dependent on baseline concentrations: a pooled analysis of 12 randomised controlled trials

European journal of nutrition, 2013-02, Vol.52 (1), p.153-160

2013

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

The New England journal of medicine, 2010-09, Vol.363 (10), p.943-953

2010

Volltextzugriff (PDF)

L’évaluation : une question centrale à propos des connaissances pédagogiques de contenu

Revue française de linguistique appliquée, 2019, Vol.XXIV (1), p.37-52

2019

Volltextzugriff (PDF)

Conceptualisation, symbolisation et interactions enseignante/enseignant-élèves dans les apprentissages mathématiques : l’exemple de la généralisation

Éducation et francophonie, 2019, Vol.47 (3), p.98-120

2019

Volltextzugriff (PDF)

2130 Tumour response outcomes during the first-line treatment of metastatic colorectal carcinoma (mCRC) with panitumumab + FOLFIRI

European journal of cancer (1990), 2015-09, Vol.51, p.S375-S376

2015

Volltextzugriff (PDF)

PD-014 First-line treatment with modified FOLFOX6 (mFOLFOX6) + panitumumab or bevacizumab in patients with RAS/BRAF wild-type (WT) metastatic colorectal carcinoma (mCRC)

Annals of oncology, 2015-06, Vol.26, p.iv105

2015

Volltextzugriff (PDF)

PD-024Retrospective analysis of quality of life and early tumour shrinkage during first-line FOLFOX4 ± panitumumab in RAS wild-type metastatic colorectal carcinoma

Annals of oncology, 2016-06, Vol.27 (Suppl 2), p.ii110-ii111

2016

Volltextzugriff (PDF)

PD-024 Retrospective analysis of quality of life and early tumour shrinkage during first-line FOLFOX4 ± panitumumab in RAS wild-type metastatic colorectal carcinoma

Annals of oncology, 2016-06, Vol.27, p.ii110

2016

Volltextzugriff (PDF)

PD-024Retrospective analysis of quality of life and early tumour shrinkage during first-line FOLFOX4 plus or minus panitumumab in RAS wild-type metastatic colorectal carcinoma

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii110-ii111

2016

Volltextzugriff (PDF)

Les expériences contemporaines de co-habitat en Région de Bruxelles-Capitale

Brussels studies, 2020-02

2020

Volltextzugriff (PDF)

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy

Gynecologic oncology, 2013-11, Vol.131 (2), p.437-444

2013

Volltextzugriff (PDF)

Approche par problème et formation d’enseignants de mathématiques : comment se diffusent, en formation, les résultats de la recherche ?

Annales de didactique et de sciences cognitives, 2023-02 (Thématique 1), p.315-339

Demonty, Isabelle

2023

Volltextzugriff (PDF)

Epithelial Ovarian Cancer: Rationale for Changing the One-Fits-All Standard Treatment Regimen to Subtype-Specific Treatment

International journal of gynecological cancer, 2014-03, Vol.24 (3), p.468-477

2014

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(56)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(53)
Female
(27)
Adult
(24)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Male
(21)
Middle Aged
(15)
Aged
(12)
Biological And Medical Sciences
(12)
Hiv Infections - Drug Therapy
(8)
Adolescent
(7)
Medical Sciences
(7)
Education & Enseignement
(6)
Education & Instruction
(6)
Multiple Sclerosis
(6)
Multiple Sclerosis - Drug Therapy
(6)
Sciences Sociales & Comportementales, Psychologie
(6)
Social & Behavioral Sciences, Psychology
(6)
Aids/hiv
(5)
Animals
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

BLADDER CANCER IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH CYCLOPHOSPHAMIDE

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years

Failure of basic protein therapy for multiple sclerosis

Biochemical findings in multiple sclerosis. II. A detailed study of the serum IgA, IgG and IgM levels of 772 MS patients compared with 226 neurological controls

Treatment of chronic hepatitis C in patients with human immunodeficiency virus (HIV) with weekly peginterferon alpha-2b plus ribavirin: a multi-centred Belgian study

Modulation of immunity in multiple sclerosis: a double-blind levamisole-placebo controlled study in 85 patients

BLADDER CANCER IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH CYCLOPHOSPHAMIDE

Clinical study of sodium dantroline (Dantrium) in multiple sclerosis (author's transl)

Effects of immunosuppressive agents and particularly of cyclophosphamide on lymphocytes subsets in treated multiple sclerosis patients

Continuous Dose-Response Relationship of the LDL-Cholesterol-Lowering Effect of Phytosterol Intake

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

The effect of plant sterols on serum triglyceride concentrations is dependent on baseline concentrations: a pooled analysis of 12 randomised controlled trials

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

L’évaluation : une question centrale à propos des connaissances pédagogiques de contenu

Conceptualisation, symbolisation et interactions enseignante/enseignant-élèves dans les apprentissages mathématiques : l’exemple de la généralisation

2130 Tumour response outcomes during the first-line treatment of metastatic colorectal carcinoma (mCRC) with panitumumab + FOLFIRI

PD-014 First-line treatment with modified FOLFOX6 (mFOLFOX6) + panitumumab or bevacizumab in patients with RAS/BRAF wild-type (WT) metastatic colorectal carcinoma (mCRC)

PD-024Retrospective analysis of quality of life and early tumour shrinkage during first-line FOLFOX4 ± panitumumab in RAS wild-type metastatic colorectal carcinoma

PD-024 Retrospective analysis of quality of life and early tumour shrinkage during first-line FOLFOX4 ± panitumumab in RAS wild-type metastatic colorectal carcinoma

PD-024Retrospective analysis of quality of life and early tumour shrinkage during first-line FOLFOX4 plus or minus panitumumab in RAS wild-type metastatic colorectal carcinoma

Les expériences contemporaines de co-habitat en Région de Bruxelles-Capitale

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy

Approche par problème et formation d’enseignants de mathématiques : comment se diffusent, en formation, les résultats de la recherche ?

Epithelial Ovarian Cancer: Rationale for Changing the One-Fits-All Standard Treatment Regimen to Subtype-Specific Treatment

Suchergebnisse filtern